This is a public record generated listing.
Assets of Pharmaceutical Company
Listing Information
Attachments
Assets of Pharmaceutical Company
Price: Not Specified
Other Item Info
Item #: debke_177019
Created: 06/11/2019
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Location: New York, New York
Sale Date: Sat. Aug 3, 2019
Created: 06/11/2019
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Location: New York, New York
Sale Date: Sat. Aug 3, 2019
Seller Info
Zachary I Shapiro
Debtor's Attorney
920 North King Street, P.O. Box 551
Wilmington, DE 19801
302-651-7700
Debtor's Attorney
920 North King Street, P.O. Box 551
Wilmington, DE 19801
302-651-7700
Bankruptcy Info
Case #: 1:19-bk-11292
Case Title: Insys Therapeutics, Inc.
Court: Delaware Bankruptcy Court
Chapter: 11
View Case Docket
Case Title: Insys Therapeutics, Inc.
Court: Delaware Bankruptcy Court
Chapter: 11
View Case Docket
Description
Sale of assets of Insys Therapeutics, Inc. related to each of (i) Subsys, (ii) SYNDROS® (“Syndros”) and other assets related to Cannabidiol Oral Solution, a synthetic cannabidiol (“CBD”), (iii) the Sellers’ epinephrine nasal spray product candidate (“Epinephrine”), (iv) the Sellers’ naloxone nasal spray product candidate (“Naloxone”), (v) the Sellers’ buprenorphine sublingual spray (“Buprenorphine,” and collectively with assets related to Subsys, Syndros, CBD, Epinephrine.
Financial Overview
Income and Expenses ($)
months
Revenue/Gross Income:
Total Expenses:
Cash Flow:
Asset and Liability Summary ($)
Receivables:
Inventory:
FF&E:
Real Estate:
Total Assets:
Liabilities to assume:
Additional Details
-
Auction Time: 10:00 A.M
- Sale hearing on August 19, 2019
- Bid deposit: five percent (5%) of the net present value of the proposed purchase price
- Bid deadline: July 23, 2019
- Last date to respond: August 13, 2019